Glycemic-Lipid Metabolism Index

1 paper2 findings

Associations

Cardiometabolic multimorbidity

upin humans1HR 2.2

1 study

Glycemic-Lipid Metabolism Index predicts cardiometabolic multimorbidity in humans (AUCs 0.717 (3-year) and 0.692 (5-year)).
“The 3- and 5-year AUCs for GLMI were 0.717 and 0.692, respectively.”
Humans3- and 5-year AUCn = 12,096
Predictive Value of the Glycemic-Lipid Metabolism Index for Incident Cardiometabolic Multimorbidity Among Middle-Aged and Older Chinese Adults: A Prospective Cohort Study Based on CHARLS
Research Square20 Aug 2026Preprint
Glycemic-Lipid Metabolism Index raises the risk of cardiometabolic multimorbidity in humans (HR = 2.20; 95% CI: 1.83–2.64).
“Compared with Q1, participants in Q4 had a higher risk of CMM in Model 2 (HR = 2.20; 95% CI: 1.83–2.64; P < 0.001).”
HumansQ4 compared with Q1 in Model 2n = 12,096
Predictive Value of the Glycemic-Lipid Metabolism Index for Incident Cardiometabolic Multimorbidity Among Middle-Aged and Older Chinese Adults: A Prospective Cohort Study Based on CHARLS
Research Square20 Aug 2026Preprint

1 in 12 months

Research Square22 Aug

Preprint: cohort study of 12,096 peopleCardiometabolic multimorbidity